|
 |
|
|
|||
|
 |
|
Nov. 6, 2025 Source: Nutrien news release SASKATOON, Saskatchewan -- Nutrien Ltd. (TSX and NYSE: NTR) announced today its third quarter 2025 results, with net earnings of $0.5 billion ($0.96 diluted net earnings per share). Third quarter 2025 adjusted EBITDA1 was $1.4 billion and adjusted net earnings per share1 was $0.97. "Nutrien delivered structural earnings growth in the first nine months of 2025 through record upstream fertilizer sales volumes, improved reliability and higher Retail earnings, while lowering capital expenditures and increasing cash returned to shareholders. We continue to progress our strategic initiatives and take actions to simplify our portfolio, enhancing earnings quality, improving cash conversion and supporting growth in free cash flow per share over the long term," commented Ken Seitz, Nutrien's President and CEO. "The outlook for our business is supported by expectations for healthy crop input demand and growth in global potash shipments in 2026. Our focus remains on utilizing our world-class asset base to efficiently supply our customers with the products and services they need," added Mr. Seitz. Highlights: *Generated net earnings of $1.7 billion and adjusted EBITDA of $4.8 billion in the first nine months of 2025. Adjusted EBITDA increased due to higher fertilizer net selling prices, increased upstream fertilizer sales volumes and higher Retail earnings. *Retail adjusted EBITDA increased to $1.4 billion in the first nine months of 2025 due to lower operating expenses from our cost savings initiatives and higher proprietary products gross margin. *Potash adjusted EBITDA increased to $1.8 billion in the first nine months of 2025 due to higher net selling prices and record sales volumes, supported by strong potash affordability and underlying consumption growth in key offshore markets. *Nitrogen adjusted EBITDA increased to $1.6 billion in the first nine months of 2025 due to higher net selling prices and sales volumes. Our operations delivered a record ammonia operating rate 3 of 94 percent in the first nine months of 2025, achieved through improved reliability at our sites. Returned $1.2 billion to shareholders in the first nine months of 2025 through dividends and share repurchases. We repurchased 8.3 million shares in 2025 for a total of $465 million, as of November 4, 2025. 1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted. 2 Our discussion of highlights set out on this page is a comparison of the results for the nine months ended September 30, 2025 to the results for the nine months ended September 30, 2024, unless otherwise noted. 3 Excludes Trinidad and Joffre. Strategic Actions: We are taking actions to simplify our portfolio and focus on core assets to enhance earnings quality and free cash flow. We are initiating a review of strategic alternatives for our Phosphate business, which could include reconfiguring operations, strategic partnerships or a potential sale. We intend to solidify the optimal path for our Phosphate business in 2026. On October 23, 2025, we completed a controlled shut down of our Trinidad Nitrogen facility due to uncertainty with respect to port access and a lack of reliable and economic gas supply that has reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period of time. We continue to engage with stakeholders and assess options to enhance the long-term financial performance of our Trinidad operations. On September 8, 2025, we announced an agreement to sell our 50 percent equity interest in Profertil S.A. for approximately $0.6 billion, increasing expected gross proceeds from asset divestitures to approximately $0.9 billion over the last twelve months. We intend to allocate the sale proceeds to initiatives consistent with our capital allocation priorities, including targeted growth investments, share repurchases and debt reduction. To read the entire report click here. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
